Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

338 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial.
Ismail-Beigi F, Craven T, Banerji MA, Basile J, Calles J, Cohen RM, Cuddihy R, Cushman WC, Genuth S, Grimm RH Jr, Hamilton BP, Hoogwerf B, Karl D, Katz L, Krikorian A, O'Connor P, Pop-Busui R, Schubart U, Simmons D, Taylor H, Thomas A, Weiss D, Hramiak I; ACCORD trial group. Ismail-Beigi F, et al. Lancet. 2010 Aug 7;376(9739):419-30. doi: 10.1016/S0140-6736(10)60576-4. Epub 2010 Jun 30. Lancet. 2010. PMID: 20594588 Free PMC article. Clinical Trial.
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes.
Lincoff AM, Brown-Frandsen K, Colhoun HM, Deanfield J, Emerson SS, Esbjerg S, Hardt-Lindberg S, Hovingh GK, Kahn SE, Kushner RF, Lingvay I, Oral TK, Michelsen MM, Plutzky J, Tornøe CW, Ryan DH; SELECT Trial Investigators. Lincoff AM, et al. N Engl J Med. 2023 Dec 14;389(24):2221-2232. doi: 10.1056/NEJMoa2307563. Epub 2023 Nov 11. N Engl J Med. 2023. PMID: 37952131 Clinical Trial.
Coordinating Cardiology clinics randomized trial of interventions to improve outcomes (COORDINATE) - Diabetes: rationale and design.
Nelson AJ, Pagidipati NJ, Kelsey MD, Ardissino M, Aroda VR, Cavender MA, Lopes RD, Al-Khalidi HR, Braceras R, Gaynor T, Kaltenbach LA, Kirk JK, Lingvay I, Magwire ML, O'Brien EC, Pak J, Pop-Busui R, Richardson CR, Levya M, Senyucel C, Webb L, McGuire DK, Green JB, Granger CB. Nelson AJ, et al. Am Heart J. 2023 Feb;256:2-12. doi: 10.1016/j.ahj.2022.10.079. Epub 2022 Oct 21. Am Heart J. 2023. PMID: 36279931 Clinical Trial.
Coordinated Care to Optimize Cardiovascular Preventive Therapies in Type 2 Diabetes: A Randomized Clinical Trial.
Pagidipati NJ, Nelson AJ, Kaltenbach LA, Leyva M, McGuire DK, Pop-Busui R, Cavender MA, Aroda VR, Magwire ML, Richardson CR, Lingvay I, Kirk JK, Al-Khalidi HR, Webb L, Gaynor T, Pak J, Senyucel C, Lopes RD, Green JB, Granger CB; COORDINATE–Diabetes Site Investigators. Pagidipati NJ, et al. JAMA. 2023 Apr 18;329(15):1261-1270. doi: 10.1001/jama.2023.2854. JAMA. 2023. PMID: 36877177 Free PMC article. Clinical Trial.
SYNTAX Score and Long-Term Outcomes: The BARI-2D Trial.
Ikeno F, Brooks MM, Nakagawa K, Kim MK, Kaneda H, Mitsutake Y, Vlachos HA, Schwartz L, Frye RL, Kelsey SF, Waseda K, Hlatky MA; BARI-2D Study Group. Ikeno F, et al. J Am Coll Cardiol. 2017 Jan 31;69(4):395-403. doi: 10.1016/j.jacc.2016.10.067. J Am Coll Cardiol. 2017. PMID: 28126156 Free article.
Barriers and new opportunities in developing effective therapies for diabetic neuropathy: International expert consensus recommendations.
Brock C, Andersen H, Alibegovic AC, Andersen ST, Andreasen LJ, Charles MH, Christensen DH, Drewes AM, Gall MA, Gylfadottir SS, Hansen CS, Hecquet SK, Jensen TS, Karlsson P, Knudsen LB, Lobato CB, Kufaishi H, Maalmi H, Mizrak HI, Nilsen KB, Perkins BA, Røikjer J, Rossing P, Rungby J, Rømer J, Stouge A, Sulek K, Søfteland E, Tahrani AA, Terkelsen AJ, Tesfaye S, Wegeberg A, Åkerström T, Brock B, Pop-Busui R. Brock C, et al. Among authors: pop busui r. Diabetes Res Clin Pract. 2025 Jan 22:112010. doi: 10.1016/j.diabres.2025.112010. Online ahead of print. Diabetes Res Clin Pract. 2025. PMID: 39855602
Inflammatory Markers and Measures of Cardiovascular Autonomic Neuropathy in Type 1 Diabetes.
Ang L, Gunaratnam S, Huang Y, Dillon BR, Martin CL, Burant A, Reiss J, Blakely P, Vasbinder A, Zhao L, Mizokami-Stout K, Tang Y, Feldman EL, Doria A, Spino C, Banerjee M, Hayek SS, Pop-Busui R. Ang L, et al. Among authors: pop busui r. J Am Heart Assoc. 2025 Jan 7;14(1):e036787. doi: 10.1161/JAHA.124.036787. Epub 2024 Dec 27. J Am Heart Assoc. 2025. PMID: 39727210 Free article. Clinical Trial.
Discontinuation of SGLT-2i and GLP-1RA among persons with Type 2 diabetes and atherosclerotic cardiovascular disease treated in US cardiology clinics.
Nelson AJ, Kaltenbach LA, McGuire DK, Levya M, Al-Khalidi HR, Webb L, Lopes RD, Pop-Busui R, Cavender MA, Aroda VR, Magwire ML, Richardson CR, Lingvay I, Kirk JK, Pandey A, Gaynor T, Pak J, Washington A, Senyucel C, Green JB, Granger CB, Pagidipati NJ. Nelson AJ, et al. Among authors: pop busui r. Am Heart J. 2024 Dec 21;282:51-57. doi: 10.1016/j.ahj.2024.12.006. Online ahead of print. Am Heart J. 2024. PMID: 39716628
338 results